Form 8-K AbbVie Inc. For: Oct 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
AbbVie reports $2.7 billion IPR&D expense to impact Q3 earnings
October 3, 2025 4:10 PM EDTAbbVie Inc. (NYSE: ABBV) announced that its third quarter 2025 earnings will include $2.7 billion in acquired intellectual property research and development and milestones expense on a pre-tax basis. The pharmaceutical company said this expense will reduce both GAAP diluted earnings per share and adjusted... More
